Ulf Bergman

173 papers receiving 6.3k citations

Ulf Bergman's Hit Papers

The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months 2006 · 1.5k citations
1.5k0+6+13Years since publication50010001.5k

Peers

Ulf Bergman
Comparison fields: 5 of 161
  • Applied Microbiology and Biotechnology 344
  • Geriatrics and Gerontology 514
  • Toxicology 388
  • Family Practice 164
  • Psychiatry and Mental health 620
Replace Björn Wettermark with:
Björn Wettermark Sweden
Anton Pottegård Denmark
Gianluca Trifirò Italy
Daniel C. Malone United States
David W. Bates United States
Ebba Holme Hansen Denmark
G. Caleb Alexander United States
Joshua J. Gagne United States
Imti Choonara United Kingdom
Michael A. Steinman United States
Ulf Bergman relative to Björn Wettermark Sweden Björn Wettermark's profile →
Citations per field
00.5×2.8×
Björn Wettermark · 1×
Citations per year

Countries citing papers authored by Ulf Bergman

Since Specialization
Citations

This map shows the geographic impact of Ulf Bergman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulf Bergman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulf Bergman more than expected).

Fields of papers citing papers by Ulf Bergman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulf Bergman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulf Bergman. The network helps show where Ulf Bergman may publish in the future.

Co-authors

The 25 scholars most cited alongside Ulf Bergman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ulf Bergman Line = papers co-authored together Ulf Bergman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 177 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months
Hit paper breakdown →
20061523
2 2011187
3 2013157
4 2007153
5 1998150
6 2011139
7 1988134
8 2010117
9 2016117
10 1981114
11 1996104
12 1994102
13 2001102
14 201392
15 200792
16 201484
17 199779
18 199277
19 199972
20 197871

About Ulf Bergman

Ulf Bergman is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health, Geriatrics and Gerontology, General Economics, Econometrics and Finance and Psychiatry and Mental health, having authored 177 papers that have together received 6.6k indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (19 papers), Monetary Policy and Economic Impact (17 papers), Pharmaceutical studies and practices (15 papers), Antibiotic Use and Resistance (13 papers), Pharmacovigilance and Adverse Drug Reactions (13 papers), Global Financial Crisis and Policies (11 papers), Fiscal Policies and Political Economy (11 papers) and Medication Adherence and Compliance (9 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (344 citations), Geriatrics and Gerontology (514 citations), Toxicology (388 citations), Family Practice (164 citations) and Psychiatry and Mental health (620 citations). Ulf Bergman has collaborated with scholars based in Sweden, United States and Denmark. Frequent co-authors include Björn Wettermark, Anders Sundström, B Westerholm, Göran Isacsson, Niklas Hammar, Petra Otterblad Olausson, Ingemar Persson, Måns Rosén, B.‐E. Wiholm and Michael M. Hutchison. Their work appears in journals such as European Journal of Clinical Pharmacology, Pharmacoepidemiology and Drug Safety, British Journal of Clinical Pharmacology, Drug Safety and Journal of Clinical Epidemiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact